Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

The FDA has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a ...

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.

Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...